ASCO 2026 - Dr. Zahi Mitri on ASCO 2026's Most Impactful Breast Cancer Data

Dr. Mitri highlights the ASCO 2026 studies most likely to shape breast cancer care, from ADCs and HER2-targeted therapies to oral SERDs, ctDNA-guided treatment, and genomic testing.